The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France

Abstract

The CARMEN-France registry is a prospective, multicenter registry in France including adult patients with a new diagnosis of immune thrombocytopenia or of autoimmune immune hemolytic anemia (2402 patients included in December 31, 2023). The recording of clinical, biological and treatment data allows detailed epidemiological and pharmacoepidemiological real-world studies. This review summarizes the CARMEN-France registry protocol, gives examples of studies conducted in the registry, and indicates future directions such as inclusion of patient reported outcomes, linkage with the French national health insurance database and linkage with other registries in Europe.

Keywords: Anémie hémolytique auto-immune; Autoimmune immune hemolytic anemia; Données de vraie vie; Epidemiology; Immune thrombocytopenia; Pharmaco-épidémiologique; Pharmacoepidemiology; Postmarketing evaluation; Purpura thrombopénique immunologique; Real-world data; Real-world evidence; Registres; Registry; Épidémiologie; Évaluation post-marketing.